Ski protein levels increase during in vitro progression of HPV16-immortalized human keratinocytes and in cervical cancer

Virology

Volumn 444, Issue 1-2, 2013, Pages 100-108

  Chen, Yi ^a,c   Pirisi, Lucia ^a   Creek, Kim E ^b  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Cervical cancer; HPV16 mediated transformation; Human keratinocytes; Human papillomavirus; Ski; TGF beta

Indexed keywords

ONCOPROTEIN; SKI PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL IMMORTALIZATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IN VITRO STUDY; KERATINOCYTE; MITOSIS INHIBITION; MOLECULAR PATHOLOGY; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; STEADY STATE; UTERINE CERVIX CANCER;

CERVICAL CANCER; HPV16-MEDIATED TRANSFORMATION; HUMAN KERATINOCYTES; HUMAN PAPILLOMAVIRUS; SKI; TGF-BETA;

DNA-BINDING PROTEINS; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMAN PAPILLOMAVIRUS 16; HUMANS; KERATINOCYTES; PROTO-ONCOGENE PROTEINS; TRANSFORMING GROWTH FACTOR BETA1; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 84882874863     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.05.039     Document Type: Article

References (50)

1. Akiyoshi S., Inoue H., Hanai J., Kusanagi K., Nemoto N., Miyazono K., Kawabata M. c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads. J. Biol. Chem. 1999, 274:35269-35277.
2. Apt D., Chong T., Liu Y., Bernard H.U. Nuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16. J. Virol. 1993, 67:4455-4463.
3. Baldwin A., Pirisi L., Creek K.E. NFI-Ski interactions mediate transforming growth factor beta modulation of human papillomavirus type 16 early gene expression. J. Virol 2004, 78:3953-3964.
4. Band A.M., Bjorklund M., Laiho M. The phosphatidylinositol 3-kinase/Akt pathway regulates transforming growth factor-{beta} signaling by destabilizing ski and inducing Smad7. J. Biol. Chem 2009, 284:35441-35449.
5. Bonnon C., Atanasoski S. c-Ski in health and disease. Cell Tissue Res 2012, 347:51-64.
6. Buess M., Terracciano L., Reuter J., Ballabeni P., Boulay J.L., Laffer U., Metzger U., Herrmann R., Rochlitz C. Amplification of SKI is a prognostic marker in early colorectal cancer. Neoplasia 2004, 6:207-212.
7. Colmenares C., Stavnezer E. The ski oncogene induces muscle differentiation in quail embryo cells. Cell 1989, 59:293-303.
8. Colmenares C., Sutrave P., Hughes S.H., Stavnezer E. Activation of the c-ski oncogene by overexpression. J. Virol. 1991, 65:4929-4935.
9. Creek K.E., Geslani G., Batova A., Pirisi L. Progressive loss of sensitivity to growth control by retinoic acid and transforming growth factor-beta at late stages of human papillomavirus type 16-initiated transformation of human keratinocytes. Adv. Exp. Med. Biol 1995, 375:117-135.
10. Deheuninck J., Luo K. Ski and SnoN, potent negative regulators of TGF-beta signaling. Cell Res 2009, 19:47-57.
11. Ferrand N., Atfi A., Prunier C. The oncoprotein c-ski functions as a direct antagonist of the transforming growth factor-{beta} type I receptor. Cancer Res 2010, 70:8457-8466.
12. Fukuchi M., Nakajima M., Fukai Y., Miyazaki T., Masuda N., Sohda M., Manda R., Tsukada K., Kato H., Kuwano H. Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma. Int. J. Cancer 2004, 108:818-824.
13. Fumagalli S., Doneda L., Nomura N., Larizza L. Expression of the c-ski proto-oncogene in human melanoma cell lines. Melanoma Res 1993, 3:23-27.
14. He J., Tegen S.B., Krawitz A.R., Martin G.S., Luo K. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins. J. Biol. Chem. 2003, 278:30540-30547.
15. Heider T.R., Lyman S., Schoonhoven R., Behrns K.E. Ski promotes tumor growth through abrogation of transforming growth factor-beta signaling in pancreatic cancer. Ann. Surg 2007, 246:61-68.
16. Hussein M.R. Transforming growth factor-beta and malignant melanoma: molecular mechanisms. J. Cutan. Pathol. 2005, 32:389-395.
17. Hypes M.K., Pirisi L., Creek K.E. Mechanisms of decreased expression of transforming growth factor-beta receptor type I at late stages of HPV16-mediated transformation. Cancer Lett. 2009, 282:177-186.
18. Jacob C., Grabner H., Atanasoski S., Suter U. Expression and localization of Ski determine cell type-specific TGFbeta signaling effects on the cell cycle. J. Cell Biol 2008, 182:519-530.
19. Kokura K., Kim H., Shinagawa T., Khan M.M., Nomura T., Ishii S. The Ski-binding protein C184M negatively regulates tumor growth factor-beta signaling by sequestering the Smad proteins in the cytoplasm. J. Biol. Chem 2003, 278:20133-20139.
20. Larsen J., Beug H., Hayman M.J. The v-ski oncogene cooperates with the v-sea oncogene in erythroid transformation by blocking erythroid differentiation. Oncogene 1992, 7:1903-1911.
21. Larsen J., Meyer S., Steinlein P., Beug H., Hayman M.J. Transformation of chicken bone marrow cells by the v-ski oncogene. Oncogene 1993, 8:3221-3228.
22. Le Scolan E., Zhu Q., Wang L., Bandyopadhyay A., Javelaud D., Mauviel A., Sun L., Luo K. Transforming growth factor-beta suppresses the ability of Ski to inhibit tumor metastasis by inducing its degradation. Cancer Res. 2008, 68:3277-3285.
23. Li Y., Turck C.M., Teumer J.K., Stavnezer E. Unique sequence, ski, in Sloan-Kettering avian retroviruses with properties of a new cell-derived oncogene. J. Virol. 1986, 57:1065-1072.
24. Liu X., Sun Y., Weinberg R.A., Lodish H.F. Ski/Sno and TGF-beta signaling. Cytokine Growth Factor Rev. 2001, 12:1-8.
25. Luo K., Stroschein S.L., Wang W., Chen D., Martens E., Zhou S., Zhou Q. The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. Genes Dev. 1999, 13:2196-2206.
26. Macdonald M., Wan Y., Wang W., Roberts E., Cheung T.H., Erickson R., Knuesel M.T., Liu X. Control of cell cycle-dependent degradation of c-Ski proto-oncoprotein by Cdc34. Oncogene 2004, 23:5643-5653.
27. Marcelain K., Hayman M.J. The Ski oncoprotein is upregulated and localized at the centrosomes and mitotic spindle during mitosis. Oncogene 2005, 24:4321-4329.
28. Marcelain K., Armisen R., Aguirre A., Ueki N., Toro J., Colmenares C., Hayman M.J. Chromosomal instability in mouse embryonic fibroblasts null for the transcriptional co-repressor Ski. J. Cell Physiol. 2012, 227:278-287.
29. Medrano E.E. Repression of TGF-beta signaling by the oncogenic protein SKI in human melanomas: consequences for proliferation, survival, and metastasis. Oncogene 2003, 22:3123-3129.
30. Mi Y., Borger D.R., Fernandes P.R., Pirisi L., Creek K.E. Loss of transforming growth factor-beta (TGF-beta) receptor type I mediates TGF-beta resistance in human papillomavirus type 16-transformed human keratinocytes at late stages of in vitro progression. Virology 2000, 270:408-416.
31. Mosquera J., Armisen R., Zhao H., Rojas D.A., Maldonado E., Tapia J.C., Colombo A., Hayman M.J., Marcelain K. Identification of Ski as a target for Aurora A kinase. Biochem. Biophys. Res. Commun. 2011, 409:539-543.
32. Nagano Y., Koinuma D., Miyazawa K., Miyazono K. Context-dependent regulation of the expression of c-Ski protein by Arkadia in human cancer cells. J. Biochem. 2010, 147:545-554.
33. Nagata M., Goto K., Ehata S., Kobayashi N., Saitoh M., Miyoshi H., Imamura T., Miyazawa K., Miyazono K. Nuclear and cytoplasmic c-Ski differently modulate cellular functions. Genes Cells 2006, 11:1267-1280.
34. Nagata M., Nagata S., Yuki K., Isogaya K., Saitoh M., Miyazono K., Miyazawa K. Identification of a phosphorylation site in c-Ski as serine 515. J. Biochem. 2010, 148:423-427.
35. Nomura T., Khan M.M., Kaul S.C., Dong H.D., Wadhwa R., Colmenares C., Kohno I., Ishii S. Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor. Genes Dev. 1999, 13:412-423.
36. Pirisi L., Yasumoto S., Feller M., Doniger J., DiPaolo J.A. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J. Virol. 1987, 61:1061-1066.
37. Pirisi L., Creek K.E., Doniger J., DiPaolo J.A. Continuous cell lines with altered growth and differentiation properties originate after transfection of human keratinocytes with human papillomavirus type 16 DNA. Carcinogenesis 1988, 9:1573-1579.
38. Prunier C., Pessah M., Ferrand N., Seo S.R., Howe P., Atfi A. The oncoprotein Ski acts as an antagonist of transforming growth factor-beta signaling by suppressing Smad2 phosphorylation. J. Biol. Chem. 2003, 278:26249-26257.
39. Reed J.A., Bales E., Xu W., Okan N.A., Bandyopadhyay D., Medrano E.E. Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling. Cancer Res. 2001, 61:8074-8078.
40. Reed J.A., Lin Q., Chen D., Mian I.S., Medrano E.E. SKI pathways inducing progression of human melanoma. Cancer Metastasis Rev. 2005, 24:265-272.
41. Ritter M., Kattmann D., Teichler S., Hartmann O., Samuelsson M.K., Burchert A., Bach J.P., Kim T.D., Berwanger B., Thiede C., Jager R., Ehninger G., Schafer H., Ueki N., Hayman M.J., Eilers M., Neubauer A. Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia. Leukemia 2006, 20:437-443.
42. Shinagawa T., Nomura T., Colmenares C., Ohira M., Nakagawara A., Ishii S. Increased susceptibility to tumorigenesis of ski-deficient heterozygous mice. Oncogene 2001, 20:8100-8108.
43. Sun Y., Liu X., Ng-Eaton E., Lodish H.F., Weinberg R.A. SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling. Proc. Nat. Acad. Sci. U.S.A. 1999, 96:12442-12447.
44. Sun Y., Liu X., Eaton E.N., Lane W.S., Lodish H.F., Weinberg R.A. Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling. Mol. Cell 1999, 4:499-509.
45. Suzuki H., Yagi K., Kondo M., Kato M., Miyazono K., Miyazawa K. c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements. Oncogene 2004, 23:5068-5076.
46. Tarapore P., Richmond C., Zheng G., Cohen S.B., Kelder B., Kopchick J., Kruse U., Sippel A.E., Colmenares C., Stavnezer E. DNA binding and transcriptional activation by the Ski oncoprotein mediated by interaction with NFI. Nucleic Acids Res. 1997, 25:3895-3903.
47. Villanacci V., Bellone G., Battaglia E., Rossi E., Carbone A., Prati A., Verna C., Niola P., Morelli A., Grassini M., Bassotti G. Ski/SnoN expression in the sequence metaplasia-dysplasia-adenocarcinoma of Barrett's esophagus. Hum. Pathol. 2008, 39:403-409.
48. Xu W., Angelis K., Danielpour D., Haddad M.M., Bischof O., Campisi J., Stavnezer E., Medrano E.E. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor. Proc. Nat. Acad. Sci. U.S.A. 2000, 97:5924-5929.
49. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J. Natl. Cancer Inst 2000, 92:690-698.
50. Zyzak L.L., MacDonald L.M., Batova A., Forand R., Creek K.E., Pirisi L. Increased levels and constitutive tyrosine phosphorylation of the epidermal growth factor receptor contribute to autonomous growth of human papillomavirus type 16 immortalized human keratinocytes. Cell Growth Differ 1994, 5:537-547.